Sale!

MYL3 Gene Cardiomyopathy Familial Hypertrophic Type 8 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The MYL3 Gene Cardiomyopathy Familial Hypertrophic Type 8 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the MYL3 gene associated with inherited hypertrophic cardiomyopathy. This comprehensive test utilizes Next Generation Sequencing technology to analyze the entire MYL3 gene, providing crucial information about genetic predisposition to this serious heart condition. The test is particularly valuable for individuals with family history of cardiomyopathy, unexplained heart symptoms, or those planning family expansion. Results help guide treatment decisions, inform lifestyle modifications, and enable proactive cardiac monitoring. The test is available for $500 USD and provides results within 3-4 weeks, offering peace of mind and actionable medical insights for patients and their families.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

MYL3 Gene Cardiomyopathy Familial Hypertrophic Type 8 NGS Genetic DNA Test

Understanding MYL3 Gene Cardiomyopathy Testing

The MYL3 Gene Cardiomyopathy Familial Hypertrophic Type 8 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics. This advanced test specifically targets mutations in the MYL3 gene, which encodes myosin light chain 3 – a critical protein component of cardiac muscle contraction. When mutations occur in this gene, they can lead to familial hypertrophic cardiomyopathy type 8, a serious inherited heart condition characterized by abnormal thickening of the heart muscle.

What This Test Measures and Detects

Our comprehensive NGS genetic analysis examines the entire MYL3 gene sequence to identify:

  • Pathogenic variants associated with hypertrophic cardiomyopathy
  • Missense mutations affecting myosin light chain function
  • Frameshift mutations that disrupt protein structure
  • Nonsense mutations leading to premature protein termination
  • Copy number variations affecting gene dosage

Who Should Consider This Genetic Test

This specialized genetic test is recommended for individuals experiencing or concerned about:

  • Unexplained chest pain or discomfort
  • Heart palpitations or irregular heartbeat
  • Shortness of breath during routine activities
  • Family history of sudden cardiac death
  • Relatives diagnosed with hypertrophic cardiomyopathy
  • Abnormal echocardiogram results showing thickened heart walls
  • Planning pregnancy with family cardiac history
  • Unexplained fainting episodes or dizziness

Clinical Importance and Benefits

Early detection through genetic testing provides numerous advantages:

  • Enables proactive cardiac monitoring and management
  • Guides appropriate treatment strategies
  • Informs family planning decisions
  • Identifies at-risk family members for screening
  • Reduces uncertainty about genetic predisposition
  • Facilitates lifestyle modifications to reduce cardiac risk
  • Provides psychological relief through definitive diagnosis

Understanding Your Test Results

Your genetic test results will fall into one of several categories:

  • Positive Result: Indicates a pathogenic mutation was identified, confirming genetic predisposition to MYL3-related cardiomyopathy. This requires immediate consultation with a cardiologist and implementation of appropriate monitoring and treatment protocols.
  • Negative Result: No disease-causing mutations were detected in the MYL3 gene, significantly reducing but not completely eliminating the risk of developing this specific form of cardiomyopathy.
  • Variant of Uncertain Significance (VUS): A genetic change was identified whose clinical significance is currently unknown. Regular follow-up and family studies may be recommended.

Test Pricing and Availability

Test Feature Details
Test Name MYL3 Gene Cardiomyopathy Familial Hypertrophic Type 8 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Comprehensive Testing Process

Our testing protocol includes essential pre-test requirements:

  • Complete clinical history documentation
  • Genetic counseling session with certified specialists
  • Detailed pedigree chart creation of affected family members
  • Professional sample collection at our certified facilities
  • State-of-the-art Next Generation Sequencing analysis
  • Comprehensive result interpretation by genetic experts

Nationwide Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified collection centers ensures accessible testing for patients nationwide.

Take Control of Your Cardiac Health Today

Don’t let uncertainty about your genetic cardiac risk affect your quality of life. Our MYL3 Gene Cardiomyopathy test provides definitive answers and empowers you to make informed healthcare decisions. Early detection can significantly impact treatment outcomes and family planning considerations.

Call us now at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our genetic specialists are available to answer your questions and guide you through the testing process with compassion and expertise.

Take the first step toward understanding your genetic cardiac risk and protecting your heart health for years to come. Contact us today to schedule your comprehensive MYL3 genetic analysis.